Risk of cancer in BRCA1 and BRCA2 mutation-positive and -negative breast cancer families (Finland)

被引：0
|
作者：
Hannaleena Eerola
Eero Pukkala
Seppo Pyrhönen
Carl Blomqvist
Risto Sankila
Heli Nevanlinna
机构：
[1] Helsinki University Central Hospital,Department of Oncology
[2] Helsinki University Central Hospital,Department of Obstetrics and Gynaecology
[3] Institute for Statistical and Epidemiological Cancer Research,Finnish Cancer Registry
[4] Turku University Hospital,Department of Oncology and Radiotherapy
[5] Uppsala University Hospital,Department of Oncology
[6] International Agency for Research on Cancer,undefined
来源：
Cancer Causes & Control | 2001年 / 12卷
关键词：
BRCA1; BRCA2; breast neoplasms; familial; risk;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Objectives: To compare the risk of cancer between BRCA1 or BRCA2 mutation-positive and -negative families.
引用
收藏
页码：739 / 746
页数：7
相关论文
共 50 条
  • [1] Risk of cancer in BRCA1 and BRCA2 mutation-positive and -negative breast cancer families (Finland)
    Eerola, H
    Pukkala, E
    Pyrhönen, S
    Blomqvist, C
    Sankila, R
    Nevanlinna, H
    [J]. CANCER CAUSES & CONTROL, 2001, 12 (08) : 739 - 746
  • [2] Report of Endometrial Cancer in Australian BRCA1 and BRCA2 Mutation-Positive Families
    Duffy, David L.
    Antill, Yoland C.
    Stewart, Colin J.
    Young, Joanne R.
    Spurdle, Amanda B.
    [J]. TWIN RESEARCH AND HUMAN GENETICS, 2011, 14 (02) : 111 - 118
  • [3] Risk of ovarian cancer in BRCA1 and BRCA2 mutation negative hereditary breast cancer families
    Kauff, ND
    Mitra, N
    Robson, ME
    Hurley, KE
    Chuai, S
    Goldfrank, D
    Wadsworth, E
    Lee, J
    Cigler, T
    Borgen, PI
    Norton, L
    Barakat, RR
    Offit, K
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (18) : 1382 - 1384
  • [4] Prospective study of breast cancer risk for mutation negative women from BRCA1 or BRCA2 mutation positive families
    Harvey, S. L.
    Milne, R. L.
    McLachlan, S. A.
    Friedlander, M. L.
    Birch, K. E.
    Weideman, P.
    Goldgar, D.
    Hopper, J. L.
    Phillips, K. A.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2011, 130 (03) : 1057 - 1061
  • [5] Prospective study of breast cancer risk for mutation negative women from BRCA1 or BRCA2 mutation positive families
    S. L. Harvey
    R. L. Milne
    S. A. McLachlan
    M. L. Friedlander
    K. E. Birch
    P. Weideman
    D. Goldgar
    J. L. Hopper
    K. A. Phillips
    [J]. Breast Cancer Research and Treatment, 2011, 130 : 1057 - 1061
  • [6] Breast cancer risk in mutation-negative members of known BRCA1/2 mutation-positive families
    Korde, L. A.
    Mueller, C. M.
    Nichols, K.
    Loud, J. T.
    Struewing, J.
    Greene, M. H.
    Mai, P. L.
    [J]. CANCER RESEARCH, 2009, 69 (02) : 134S - 134S
  • [7] Breast cancer screening by women from BRCA1 & BRCA2 mutation positive families
    Wuttke, Melanie
    Milne, Roger
    Weideman, Prue
    Picken, Sandra
    Smith, Charmaine
    Friedlander, Michael
    McLachlan, Sue-Anne
    Hopper, John L.
    Phillips, Kelly-Anne
    [J]. CANCER RESEARCH, 2015, 75
  • [8] BRCA1 and BRCA2 mutation screening in breast cancer families.
    Phelan, CM
    Lancaster, JM
    Gumbs, C
    de los Rios, P
    Abrahamson, J
    Warner, E
    Parfrey, NA
    Futreal, PA
    Narod, SA
    [J]. BRITISH JOURNAL OF CANCER, 1998, 78 : 12 - 12
  • [9] BRCA1 and BRCA2 mutation analysis in Irish breast cancer families
    McDevitt, T
    Miller, N
    Ormiston, W
    Cody, N
    Daly, PA
    McDermott, E
    Carney, DE
    Green, AJ
    Barton, DE
    AlKindi, S
    O'Malley, K
    Nolan, C
    [J]. JOURNAL OF MEDICAL GENETICS, 2000, 37 : S35 - S35
  • [10] Histopathological features of breast tumours in BRCA1, BRCA2 and mutation-negative breast cancer families
    Eerola, H
    Heikkilä, P
    Tamminen, A
    Aittomäki, K
    Blomqvist, C
    Nevanlinna, H
    [J]. BREAST CANCER RESEARCH, 2005, 7 (01) : R93 - R100
12345